To examine the modulation of Toll-like receptor 2 and CD64 on monocytes in various infectious diseases
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Our study population is patients with various inflammatory disease, from who were Informed consent was obtained in accordance with a protocol approved by the Nagasaki University Ethics Committee, and blood sample from healthy volunteers is taken as control.
Exclusion criteria
Exclusion criteria: Patients in whom 10 mL blood sampling may be have harmful effects. Severe anemia etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To excess useful baiomarkers to rapidly predict exacerbation/remission and reccurence/complete cure in infectious diseases | — |
Secondary
| Measure | Time frame |
|---|---|
| Biomarker to discriminate infectious diseases from non-infectious inflammatory diseases | — |
Countries
Japan
Contacts
Graduate School of of Biomedical Sciences, Nagasaki University Department of Molecular Microbiology and Immunology